What is the maximum allowable time for reporting to the board, DEA, and CHFS in case of pharmacy closure?

The correct time frame for reporting a pharmacy closure to the Board of Pharmacy, the Drug Enforcement Administration (DEA), and the Cabinet for Health and Family Services (CHFS) is indeed 15 days. This requirement is in place to ensure that there is continuity in patient care and to minimize any potential risks associated with the abrupt closure of a pharmacy.

Reporting within this timeframe allows the relevant authorities to properly oversee the disposition of prescription medications and to ensure that there are no disruptions in service for patients who may rely on the pharmacy for their medications.

A timeframe shorter than 15 days, such as 10 days, would not provide sufficient opportunity for pharmacies to organize their closure in a manner that allows for proper communication and documentation with regulatory bodies. On the other hand, longer reporting periods like 30 or 60 days could lead to unnecessary delays in addressing issues that may arise from the closure, potentially impacting patient safety and regulatory compliance. Therefore, the 15-day requirement strikes an appropriate balance between urgency and manageability.